INTRODUCTION
============

Advances in antiretroviral therapy have converted HIV infection into a chronic disease, resulting in patients with several comorbidities ([@b1-cln_68p1157]). HIV-related disability has been associated with decreased exercise capacity and impairment of patients\' daily activities ([@b2-cln_68p1157],[@b3-cln_68p1157]).

Thus, exercise training is a key strategy employed by patients with HIV or AIDS that is widely prescribed by rehabilitation professionals ([@b4-cln_68p1157]). The accumulated body of scientific evidence indicates that exercise training increases aerobic capacity, muscle strength, flexibility, and functional ability in patients with HIV or AIDS ([@b5-cln_68p1157]-[@b7-cln_68p1157]).

The exercise program should be modified according to an individual\'s physical function, health status, exercise response, and stated goals. The single workout must then be designed to reflect these targeted program goals, including the choice of exercises, the order of exercises, the volume (i.e., the number of repetitions, the number of sets, and the total time) of each exercise, and the intensity. Exercise intensity and volume are important determinants of physiologic responses to exercise training ([@b6-cln_68p1157],[@b7-cln_68p1157]).

Adaptations to exercise are highly dependent on the specific type of training performed. However, there is no consensus regarding which modality and intensity are more effective in patients with HIV, making it difficult to choose the best training for this population. This issue is still an obstacle in clinical practice. A better understanding of the effectiveness and safety of exercise will enable people living with HIV and their health care providers to practice effective and appropriate exercise prescription ([@b8-cln_68p1157]).

The purpose of this report was to 1) perform a systematic review of the evidence regarding the effects of different types of exercise on health in HIV-infected patients and 2) to define the best volume, intensity, and type of exercise to achieve minimal and optimal health benefits in HIV-infected patients.

METHODS
=======

This review comprised three phases. In phase 1, a database search (MEDLINE, LILACS, EMBASE, SciELO, Cumulative Index to Nursing and Allied Health (CINAHL), PEDro, and the Cochrane Library) was performed to identify relevant abstracts from up to August 2012. In the second phase, two reviewers assessed the list of studies generated by the search strategy, using the title and abstract to determine study eligibility. Full-text copies of potentially relevant studies were then obtained for detailed examination, and in phase 3, the quality of the studies was assessed.

Data Sources and Searches
-------------------------

We performed a computer-based search, querying Ovid MEDLINE (1950 to August 2012), LILACS (up to August 2012), CINAHL (Cumulative Index to Nursing and Allied Health, 1982 to August 2012), EMBASE (1980 to August 2012), PEDro (Physiotherapy Evidence Database), and the Cochrane Central Register of Controlled Trials for original research articles published in English, Spanish, or Portuguese. In the search strategy, there were four groups of keywords: study design, participants, interventions, and outcome measures.

The study design group of keywords included the terms randomized controlled trials, clinical trials, and controlled trials. The participants group included the terms human immunodeficiency virus, acquired immunodeficiency syndrome, HIV, HIV infections, HIV long-term survivors, AIDS, and HIV/AIDS. The interventions group included the terms exercise, training, physical exercise, fitness, strength training, progressive resistive/resistance aerobic, aerobic training, concurrent strength and endurance training, concurrent training, anaerobic, exercise therapy, and physical training.

The outcome measures group included the terms quality of life, health-related quality of life, life expectancy, cardiopulmonary status, aerobic fitness, aerobic capacity, strength, muscle strength, body composition, health, physiologic parameters, and functional parameters.

Study Selection
---------------

### Types of studies and participants

We included randomized controlled trials (RCTs) comparing exercise training with non-exercise training or with another therapeutic modality. The exercise was performed at least two times per week and lasted at least 4 weeks. Studies on adults (18 years and older), regardless of sex and at all stages of infection, were included.

### Types of interventions

Resistance exercise (weight training or resistance training) was defined as exercise that requires muscle contraction against resistance (e.g., body weight or barbells). Resistance training programs were described with respect to duration, frequency, intensity, volume, rest intervals, muscle group, and supervision.

Aerobic exercise (or endurance training) was defined as a regimen containing aerobic interventions (walking, cycling, rowing, and stair stepping). Aerobic training programs were described with respect to intensity, frequency, duration, and supervision.

Concurrent training was defined as the application of aerobic and resistance exercise in the same training session.

### Types of outcome measures

This systematic review was limited to key indicators of different health outcomes known to be related to exercise in HIV-infected patients. Decisions regarding what health outcomes to include in the systematic review were made by examining what outcomes were studied in previously conducted RCTs and systematic reviews on HIV. These key indicators consisted of the following:

1\) Anthropometric characteristics, as a measure of body composition;

2\) Muscle strength, as a measure of musculoskeletal health;

3\) Aerobic capacity or aerobic fitness, as a measure of cardiopulmonary health; and

4\) Physical and psychological functioning, as a measure of quality of life.

The body composition measures considered in this review included but were not limited to anthropometry, lean body mass and fat mass, body mass index \[calculated as weight (kg) divided by height^2^ (m)\], and total body fat (the amount of subcutaneous fat determined using the thickness of specific skinfolds). Three trunk skinfolds (subscapular, suprailiac, and vertical abdominal) and four limb skinfolds (triceps, biceps, thigh, and medial calf); the waist circumference at the umbilicus, which is a measure of central fat (subcutaneous and visceral); and the maximum hip circumference were measured and recorded in mm. The waist-to-hip ratio (WHR) was the waist circumference at the umbilicus (mm) divided by the maximum hip circumference (mm).

The musculoskeletal health measures considered in this review also included skeletal muscle mass, muscle strength, a muscle function test, the maximum torque, the maximum force, the peak torque, the peak force, and total work.

The main cardiopulmonary measures considered in this review were the maximal oxygen consumption (VO~2~max/peak) (ml/kg/min), the absolute VO~2~, oxygen pulse (O~2~ pulse), the heart rate maximum (HRmax) (beats/min), the lactic acid threshold (LAT), fatigue (time on treadmill), exercise duration, and dyspnea (the rate of perceived exertion).

To assess the quality of life related to health, we reviewed studies that reported health-related quality of life based on standardized and validated scales or questionnaires.

Data extraction and quality assessment
--------------------------------------

All authors worked independently and used a standard form adapted from the Cochrane Collaboration\'s ([@b9-cln_68p1157]) model for data extraction, considering 1) aspects of the study population, such as the average age and sex; 2) aspects of the intervention performed (sample size, type of exercise performed, presence of supervision, frequency, and duration of each session); 3) follow-up; 4) loss to follow-up; 5) outcome measures; and 6) presented results.

There are several scales for assessing the quality of RCTs. The PEDro scale assesses the methodological quality of a study based on important criteria, such as concealed allocation, intention-to-treat analysis, and the adequacy of follow-up. These characteristics make the PEDro scale a useful tool for assessing the quality of physical therapy and rehabilitation trials ([@b10-cln_68p1157]).

Methodological quality was independently assessed by two researchers. Studies were scored on the PEDro scale based on a Delphi list ([@b11-cln_68p1157]) that consisted of 11 items. One item on the PEDro scale (eligibility criteria) is related to external validity and is generally not used to calculate the method score, leaving a score range of 0 to 10 ([@b12-cln_68p1157]). Studies were excluded in the subsequent analysis if the cutoff of four points was not reached. Any disagreements were resolved by a third rater.

Data synthesis and analysis
---------------------------

If the inclusion criteria were not clearly described in a particular study, the authors were contacted, and a consensus among the reviewers was obtained to decide whether the study would be part of the review. We also performed a manual tracking of citations in the selected articles.

RESULTS
=======

The flow chart for our study is shown in [Figure 1](#f1-cln_68p1157){ref-type="fig"}. In total, 59 studies were sent to the reviewers for evaluation, selection, and inclusion in the review.

After assessment, 24 studies were excluded, and 35 papers met the entry criteria. Of these, four were duplicates (studies that used the same participants), as Sattler et al. 2002 ([@b16-cln_68p1157]) used the same participants as Sattler et al. 1999 ([@b21-cln_68p1157]); Lox et al. 1996 ([@b22-cln_68p1157]) used the same participants as Lox et al. 1995 ([@b23-cln_68p1157]); Multimura et al. 2008 ([@b37-cln_68p1157]) used the same participants as Multimura et al. 2008 ([@b36-cln_68p1157]); and Fairfield et al. 2001 ([@b45-cln_68p1157]) used the same participants as Grinspoon et al. 2000 ([@b46-cln_68p1157]).

The remaining 31 articles were fully analyzed and approved by both reviewers, and the data were extracted from each RCT. Each of the papers was assessed by both reviewers using PEDro scale methodology with the predefined cutoff ([@b4-cln_68p1157]). The results of the assessment using the PEDro scale are individually presented in [Table 1](#t1-cln_68p1157){ref-type="table"}. Two other studies \[Galantino et al. 2006 ([@b26-cln_68p1157]) and McArthur et al. 1993 ([@b33-cln_68p1157])\] were excluded because these papers did not reach the defined minimal score on the PEDro scale.

Of the 29 articles included in this review, eight were on resistance exercise compared with a control or supplementation ([@b13-cln_68p1157],[@b15-cln_68p1157],[@b17-cln_68p1157]),, eight were on aerobic exercise ([@b25-cln_68p1157],[@b27-cln_68p1157]), compared with a control, 11 compared concurrent training with a control group ([@b35-cln_68p1157],[@b36-cln_68p1157],[@b38-cln_68p1157],[@b39-cln_68p1157]),, and two compared resistance exercise with aerobic exercise ([@b14-cln_68p1157],[@b23-cln_68p1157]).

The participants included adults infected with HIV at various stages of the disease, with CD4 counts ranging from \<100 to \>500 cells/mm^3^. Patients with elements of wasting syndrome (either \>5% or \>10% involuntary weight loss or body weight \<90% of the ideal body weight) were also included. The studies included patients of both sexes, but there was a predominance of males (77%). The sample sizes, outcomes, and results of the included studies with regard to different types of exercise are summarized in [Table 2](#t2-cln_68p1157){ref-type="table"}.

Resistance exercise
-------------------

### Characteristics of the sample

The initial sample size of the selected studies ranged from 20 ([@b13-cln_68p1157],[@b17-cln_68p1157]) to 61 ([@b19-cln_68p1157]). The final sample ranged from 20 ([@b13-cln_68p1157],[@b17-cln_68p1157]) to 50 ([@b15-cln_68p1157]), and the mean age of the participants ranged from 18 to 60 years. All studies selected in this review included outpatients diagnosed with HIV, and most of these patients were receiving antiretroviral therapy. Four studies included patients of both sexes ([@b13-cln_68p1157],[@b15-cln_68p1157],[@b17-cln_68p1157],[@b19-cln_68p1157]), six included only men ([@b14-cln_68p1157]),, and one included only women ([@b18-cln_68p1157]).

### Characteristics of intervention programs

The exercise intervention characteristics of the included studies are provided in [Table 3](#t3-cln_68p1157){ref-type="table"}. The parameters used in the application of resistance exercise were reported in most studies, and all studies described the progressive nature of the training.

The duration of intervention programs with resistance ranged from 6 ([@b24-cln_68p1157]) to 16 ([@b14-cln_68p1157],[@b19-cln_68p1157]) weeks, but in 40% of the reviewed studies, the application period was 12 weeks. The duration of the session varied from 30 ([@b15-cln_68p1157]) to 90 ([@b13-cln_68p1157]) minutes, although in six studies, the duration was not reported. The frequency of sessions was three times per week in all studies.

Only two studies ([@b20-cln_68p1157],[@b23-cln_68p1157]) did not specify the type of muscle contraction performed during training. In the other studies, the exercise was performed with concentric and eccentric contractions using machines, weight stations, and free weights. The exercise intensity was based on the extent of the individual\'s one-repetition maximum (RM), ranging from 50 to 90% of the RM in 90% of the studies. One study described the intensity as the 15RM ([@b24-cln_68p1157]).

The application volume of exercise ranged from three to five sets of six to 15 repetitions (reps). In 70% of the studies, the volume was three sets of eight reps, but only two studies reported the time interval between the series, which ranged from 60 to 120 seconds ([@b14-cln_68p1157],[@b21-cln_68p1157]). All studies reported the application of exercises to large muscle groups of the lower and upper limbs.

Aerobic exercise
----------------

### Characteristics of the sample

The baseline sample in the selected studies ranged from 20 ([@b14-cln_68p1157]) to 123 ([@b28-cln_68p1157]) people. The final sample ranged from 18 ([@b14-cln_68p1157]) to 109 ([@b28-cln_68p1157]) people, and the mean age of the participants ranged from 18 to 60 years. Three studies only included males ([@b14-cln_68p1157],[@b23-cln_68p1157],[@b34-cln_68p1157]), and the remaining studies included HIV-infected patients of both sexes. All studies analyzed in this review included outpatients diagnosed with HIV, and most of these patients were receiving antiretroviral therapy.

### Characteristics of intervention programs

The duration of the intervention programs with aerobic exercise ranged from 6 ([@b32-cln_68p1157]) to 24 ([@b34-cln_68p1157]) weeks. In 60% of the studies, the application of the program lasted 12 weeks. The session duration was reported in all studies and ranged from 30 ([@b29-cln_68p1157],[@b32-cln_68p1157]) to 60 ([@b25-cln_68p1157],[@b27-cln_68p1157],[@b31-cln_68p1157]) minutes, with an average duration of 45 min. The frequency of the program was three times per week in all studies.

Most studies used either a cycle ergometer or combined exercise programs (such as a cycle ergometer and/or walking and/or jogging). The intensity of exercise was adjusted based on the HRmax in 70% of the studies. In one study ([@b29-cln_68p1157]), the VO~2~max/peak was used, and the heart rate reserve was used in another study ([@b23-cln_68p1157]). The intensity ranged from 50 to 85% of the HRmax, 50 to 85% of the VO~2~max/peak, or 50 to 85% of the heart rate reserve.

The aerobic interventions in the trials also varied according to constant compared with interval exercise and moderate compared with high-intensity exercise. [Table 4](#t4-cln_68p1157){ref-type="table"} provides details on the characteristics of the intervention programs.

Outcome measures
----------------

The most commonly reported positive effects on physiologic physical performance indicators were observed in the VO~2~max/peak, resting heart rate, HRmax, and submaximal heart rate, as shown in [Table 2](#t2-cln_68p1157){ref-type="table"}.

Concurrent training
-------------------

### Characteristics of the sample

The initial sample size of the selected studies ranged from 35 ([@b44-cln_68p1157]) to 100 ([@b36-cln_68p1157]). The final sample ranged from 31 ([@b44-cln_68p1157]) to 97 ([@b36-cln_68p1157]), and the mean age of the participants ranged from 18 to 60 years. The studies included patients of both sexes, but there was a predominance of males (70%). All studies analyzed in this review included patients diagnosed with HIV, and most of these patients were receiving antiretroviral therapy.

### Characteristics of intervention programs

The exercise intervention characteristics of the included studies are provided in [Table 5](#t5-cln_68p1157){ref-type="table"}. The duration of the intervention programs with concurrent training ranged from 6 ([@b38-cln_68p1157]) to 24 ([@b36-cln_68p1157]) weeks, but in most studies, the application period ranged from 12 to 16 weeks. The duration of the session varied from 60 ([@b40-cln_68p1157],[@b41-cln_68p1157]) to 120 ([@b42-cln_68p1157]) minutes. The frequency of sessions varied from two to three times per week, but there was a predominance of three times per week (72% of studies).

For resistance training, only two studies ([@b40-cln_68p1157],[@b42-cln_68p1157]) specified the type of muscle contraction performed during training. The exercise was performed with concentric and eccentric contractions lasting 6 to 10 seconds with the use of machines, weight stations, and free weights in six studies, but in one study, there was no description of the type of equipment used ([@b36-cln_68p1157]). The exercise intensity was based on the extent of the RM, ranging from 60% to 80% of the RM in five studies ([@b40-cln_68p1157],[@b41-cln_68p1157]),. Three studies described the intensity as the 12RM ([@b35-cln_68p1157],[@b38-cln_68p1157],[@b39-cln_68p1157]), and three studies did not report the prescribed exercise intensity ([@b36-cln_68p1157],[@b43-cln_68p1157],[@b47-cln_68p1157]). The application volume of exercise ranged from one to four sets of six to 18 reps. The volume of exercise was not described in one study ([@b36-cln_68p1157]).

For the application of aerobic exercise, all studies reported treadmill use, bike use, cycle ergometer use, walking, or jogging. Except for a study by Rigsby ([@b47-cln_68p1157]), all studies reported the criteria for progression training. In all studies, the intensity was adjusted based on the heart rate, ranging from 45% to 80% of the HRmax. The sessions of aerobic exercise began with a warm-up period of 5 to 10 min and finished with a cool-down period of 5 to 15 min. [Table 3](#t3-cln_68p1157){ref-type="table"} provides details on the characteristics of the intervention programs.

Effects of different types of therapeutic exercise
--------------------------------------------------

Resistance exercise training improved outcomes related to body composition, with increases in lean body mass ([@b13-cln_68p1157]),, mid-thigh cross-sectional muscle area ([@b15-cln_68p1157],[@b19-cln_68p1157],[@b21-cln_68p1157]), and bone mineral density ([@b13-cln_68p1157]-[@b21-cln_68p1157]), in addition to a reduction in body weight ([@b14-cln_68p1157]). Resistance exercise also generated muscle strength gain ([@b13-cln_68p1157]-[@b21-cln_68p1157]) but had little impact on quality of life ([@b15-cln_68p1157]-[@b18-cln_68p1157]).

Aerobic exercise training improved outcomes related to body composition, reducing body weight ([@b25-cln_68p1157],[@b29-cln_68p1157]), total body fat ([@b29-cln_68p1157]), and the WHR ([@b25-cln_68p1157]). A significant increase was also observed in aerobic capacity, as measured by the VO~2~max/peak ([@b25-cln_68p1157]), or time on a treadmill ([@b29-cln_68p1157]).

Concurrent training showed significant gains in body composition, with increases in lean body mass ([@b35-cln_68p1157],[@b46-cln_68p1157]), thigh muscle volume ([@b35-cln_68p1157]), and mid-thigh cross-sectional muscle area ([@b40-cln_68p1157],[@b42-cln_68p1157],[@b46-cln_68p1157]). This training reduced thigh muscle adiposity ([@b43-cln_68p1157]), the percentage of body fat ([@b36-cln_68p1157],[@b43-cln_68p1157]), and the WHR ([@b42-cln_68p1157]). Significant increases were also observed in muscle strength ([@b39-cln_68p1157],[@b40-cln_68p1157],[@b46-cln_68p1157],[@b47-cln_68p1157]); aerobic capacity, measured by the VO~2~max/peak ([@b37-cln_68p1157]-[@b40-cln_68p1157]); exercise duration ([@b42-cln_68p1157],[@b47-cln_68p1157]); and the distance covered in 6 min walking test ([@b40-cln_68p1157]), with a positive impact on quality of life ([@b36-cln_68p1157],[@b41-cln_68p1157],[@b44-cln_68p1157]). Thus, in contrast to resistance and aerobic exercise performed in isolation, concurrent training showed improvement for all evaluated outcomes.

DISCUSSION
==========

The results of this review indicate that resistance training, aerobic exercise, and concurrent training are associated with improvements in body composition, muscle strength, and cardiopulmonary fitness in adults living with HIV/AIDS.

The functional impairments of a patient should determine the exercises and activities prescribed, including the mode of exercise used ([@b48-cln_68p1157],[@b49-cln_68p1157]). The use of multiple conditioning components to address both neuromuscular strength and cardiovascular health has become an important part of most recommended exercise regimens ([@b50-cln_68p1157]).

It is important to emphasize that exercise training should be supervised by qualified professionals for the prevention of injury and to maximize the health and performance benefits ([@b51-cln_68p1157]). In 80% of the reviewed studies, the supervision of exercise by a professional was reported.

The available literature regarding the effects of exercise training in HIV is encouraging. The published trials indicate that short-term resistance exercise has physiologic benefits and positive effects on body composition and musculoskeletal health ([@b24-cln_68p1157]). Aerobic exercise directly benefits aerobic capacity ([@b32-cln_68p1157]). Concurrent training has a positive effect on body composition, aerobic capacity, muscle strength, and quality of life ([@b38-cln_68p1157],[@b41-cln_68p1157]).

In a study by Spence et al. ([@b24-cln_68p1157]), the RM was used to evaluate muscle strength. The between-group mean values for lower-extremity muscle function were significantly different (*p*\<0.01), indicating improved muscle performance in the resistance exercise group with 6 weeks of exercise. Stringer et al. ([@b32-cln_68p1157]) observed an improvement in the VO~2~max after 6 weeks of aerobic exercise. In studies by Hand et al. ([@b38-cln_68p1157]) and Fillipas et al. ([@b41-cln_68p1157]), there was an improvement in the aerobic capacity estimated in the concurrent training group, whereas no improvement was noted in the control group after 6 weeks (*p*\<0.01). Individual studies also indicate that exercise training appears to be safe ([@b52-cln_68p1157]).

Incorporating both resistance and aerobic modalities into rehabilitation programs may be more effective in optimizing functional status than programs involving only one component ([@b53-cln_68p1157]-[@b55-cln_68p1157]). In people with HIV, concurrent exercise training may decrease functional limitations and reduce physical disability resulting from HIV infection and its medical treatment ([@b56-cln_68p1157],[@b57-cln_68p1157]). Seven studies reported significant improvement in a concurrent training group compared with a control group ([@b35-cln_68p1157],[@b36-cln_68p1157],[@b38-cln_68p1157],[@b39-cln_68p1157]),.

In a study by Multimura et al. ([@b36-cln_68p1157]), the VO~2~max improved in the concurrent exercise group compared to the control (*p*\<0.001). In a study by Hand et al. ([@b38-cln_68p1157]), there was an improvement of 21% in the VO~2~ estimated in the concurrent training group and no improvement in the control group (*p*\<0.001). In the study by Filipas et al. ([@b41-cln_68p1157]), the HR was reduced in the exercise group compared with the control (*p*\<0.001).

Exercise prescription is based upon the frequency, intensity, and duration of training; the mode of activity; and the initial functional status. The interaction of these factors provides the overload stimulus and has been found to be effective for producing a training effect ([@b58-cln_68p1157],[@b59-cln_68p1157]).

Determining the appropriate exercise mode depends on patient preference and safety issues regarding the stage of the disease or other conditions. The frequency, intensity, and duration are specific to the type of activity and should be tailored to the patient\'s ability to safely perform the activity.

A minimal intensity level is likely required to receive a benefit, although the exact value is not known and may vary from one person to another. Although the optimal intensity cannot be defined based on available information, much of the exercise that is associated with good health in published reports is at least of moderate intensity ([@b58-cln_68p1157],[@b60-cln_68p1157]).

Resistance training should focus on large muscle groups, such as the chest, brachial biceps, quadriceps, and hamstrings. Again, the intensity should be moderate (set at 60% to 80% of the RM) and progressively increased. Overload should be set to match the level at which a patient can comfortably perform eight to 12 reps. For people who wish to focus on improving muscular endurance, a lower intensity (i.e., \<50% of the RM; light to moderate intensity) can be used to complete 15 to 25 repetitions per set, with the number of sets not to exceed two ([@b60-cln_68p1157],[@b61-cln_68p1157]).

Aerobic exercises should be performed at a moderate intensity, from 11 to 14 on the Borg Rating of Perceived Exertion Scale, at 50% to 85% of the HRmax, or at 45% to 85% the VO~2~max/peak. The number of weekly exercise sessions should be increased until the patient can tolerate three to five sessions weekly. In total, 30 to 60 min per day is recommended, although 20 min may be beneficial in deconditioned people ([@b60-cln_68p1157]). In all studies included in this review, the session duration ranged from 30 to 60 min. Sessions should be initiated with a warm-up period and finished with a cool-down period.

The maximum duration of the intervention in the included studies was 24 weeks, with most interventions ranging between 6 and 12 weeks. Thus, the long-term effects of exercise remain unclear.

This review has several limitations, and the results should be cautiously interpreted for several reasons. The results are based on a small number of studies. The differences in endpoints, assessment instruments, and variables of exercise prescription and the limited follow-up in several studies prevent definitive comparisons and quantitative analysis.

Meta-analyses were not performed because of the variability of the characteristics of studies pertaining to exercise and variation between individual studies in the interventions, which included the type of exercise intervention, the intensity of exercise, the length of follow-up to exercise, and outcomes.

In conclusion, considerable evidence currently exists to support a role for different types of exercise in the management of HIV-infected patients. Concurrent training showed significant gains in all outcomes evaluated and is the best type of exercise in patients with disabilities resulting from HIV. Research in the field of exercise training in people with HIV should be focused on providing indications regarding evidence-based standards for exercise prescription and on careful clinical evaluation and exercise-related risk assessment.

No potential conflict of interest was reported.
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###### 

Study quality on the PEDro scale.

       Study                    1   2   3   4   5   6   7   8   9   10   11   Total
  ---- ------------------------ --- --- --- --- --- --- --- --- --- ---- ---- ------------------------------------------------
  1    Sakkas et al. 2010       ✓   ✓   ✓   ✓   ✓   ✓           ✓   ✓    ✓    8
  2    Lindegaard et al. 2008   ✓   ✓       ✓               ✓       ✓    ✓    5
  3    Shevitz et al. 2006      ✓   ✓       ✓   ✓       ✓   ✓   ✓   ✓    ✓    8
  4    Roubenoff et al. 2001    ✓   ✓       ✓                       ✓    ✓    4
  5    Agin et al. 2001         ✓   ✓   ✓   ✓                       ✓    ✓    5
  6    Bhasin et al. 2000           ✓       ✓                   ✓   ✓    ✓    5
  7    Strawford et al. 1999        ✓   ✓   ✓   ✓   ✓       ✓       ✓    ✓    8
  8    Sattler et al. 1999          ✓       ✓               ✓       ✓         4
  9    Lox et al. 1995          ✓   ✓       ✓               ✓       ✓    ✓    5
  10   Spence et al. 1990       ✓   ✓       ✓               ✓       ✓    ✓    5
  11   Terry et al. 2006        ✓   ✓       ✓                       ✓    ✓    4
  12   Galantino et al. 2001    ✓   ✓                               ✓    ✓    3[\*](#tfn1-cln_68p1157){ref-type="table-fn"})
  13   Neidig et al. 2000           ✓       ✓                       ✓    ✓    4
  14   Smith et al. 2000        ✓   ✓       ✓           ✓           ✓    ✓    5
  15   Baigis et al. 2002       ✓   ✓   ✓   ✓                       ✓    ✓    5
  16   Perna et al. 1999        ✓   ✓       ✓                       ✓    ✓    4
  17   Terry et al. 1999        ✓   ✓       ✓                       ✓    ✓    4
  18   Stringer et al. 1999     ✓   ✓       ✓                       ✓    ✓    4
  19   McArthur et al. 1993     ✓   ✓                                    ✓    2[\*](#tfn1-cln_68p1157){ref-type="table-fn"})
  20   LaPerrieri et al. 1990   ✓   ✓       ✓                       ✓    ✓    4
  21   Yarakeshi et al. 2011    ✓   ✓       ✓               ✓       ✓    ✓    5
  22   Multimura et al. 2008    ✓   ✓       ✓               ✓       ✓    ✓    5
  23   Hand et al. 2008         ✓   ✓       ✓           ✓           ✓    ✓    5
  24   Pérez-Moreno. 2007       ✓   ✓   ✓   ✓           ✓           ✓    ✓    6
  25   Dolan et al. 2006        ✓   ✓       ✓               ✓   ✓   ✓    ✓    6
  26   Filippas et al. 2006     ✓   ✓   ✓   ✓           ✓       ✓   ✓    ✓    7
  27   Driscoll et al. 2004     ✓   ✓       ✓                       ✓    ✓    4
  28   Driscol et al. 2004      ✓   ✓       ✓                       ✓    ✓    4
  29   Rojas et al. 2003        ✓           ✓               ✓       ✓    ✓    4
  30   Grispoon et al. 2000     ✓   ✓       ✓           ✓           ✓    ✓    5
  31   Rigsby et al. 1992           ✓       ✓                       ✓    ✓    4

Excluded because PEDro \<4.

###### 

Characteristics of the outcomes and results of the trials included in the review.

       Study                      Participants (M:F)   Outcomes                                  Outcomes                               Results                                                                                                                                             
  ---- -------------------------- -------------------- ----------------------------------------- -------------------------------------- ------------------------------------ ------------------------------------------ ------------- ----------------- ---------- ------------------------ ------------
  1    Sakkas et al. 2009         HIV 43 (42:1)        Body composition Muscle strength          DEXA MRI                               1RM testing Isometric MVC            NA                                         NA            ↑ LBM             ↑ RM MVC   NA                       NA
  2    Lindegaard et al. 2008     HIV 20 (20:0)        BC Muscle strength Aerobic capacity       DEXA                                   3RM testing                          VO~2~max                                   NA            ↑ LBM ↓ BW        ↑ 3RM      ↑ VO~2~max               NA
  3    Shevitz et al. 2005        HIV 50 (33:14)       Body composition Muscle strength          DEXA CSMA                              Isokinetic dynamometer 1RM testing   TCAM6                                      HRQOL         ↑ CSMA            ↑ RM       ↑ TCAM6                  ↑ HRQOL
  4    Roubenoff,2001             HIV 20 (19:1)        Body composition Muscle strength HRQOL    DEXA                                   1RM testing                          NA                                         SF-36         ↑ LBM             ↑ RM       NA                       ↑ SF-36
  5    Agin et al. 2001           HIV 43 (0:43)        BC Muscle strength HRQOL                  DEXA MRI                               1RM testing                          NA                                         MOS-HIV       ↑ LBM             ↑ RM       NA                       ↑ MOS
  6    Basin et al. 1999          HIV 61 (NI:NI)       BC Muscle strength HRQOL                  Anthropometric measurements DEXA MRI   1RM testing                          NA                                         HRQOL         ↑ LBM ↑ CSMA      ↑ RM       NA                       ↑ HRQOL
  7    Strawford et al. 1999      HIV 24 (24:0)        Body composition Muscle strength HRQOL    DEXA                                   Isokinetic dynamometer 1RM testing   NA                                         NA            ↑ LBM             ↑ RM       NA                       NA
  8    Sattler et al. 1999        HIV 33 (33:0)        Body composition Muscle strength          BIA DEXA MRI                           1RM testing                          NA                                         NA            ↑ LBM ↑ CSMA      ↑ RM       NA                       NA
  9    Lox et al, 1995            HIV 34 (34;0)        Body composition Aerobic capacity         Anthropometric measurements            1RM testing                          VO~2~max                                   NA            ↑ LBM             ↑ RM       NA                       NA
  10   Spence et al. 1990         HIV 24 (24:0)        Body composition Muscle strength          Anthropometric measurements            Hand-held dynamometer                NA                                         NA            ↑ LBM             ↑ RM       NA                       NA
  11   Terry et al. 2006          HIV 42 (32:10)       Body composition Aerobic capacity         Anthropometric measurements            NA                                   Treadmill stress test                      NA            ↓ BW ↓ BF ↓ WHR   NA         ↑ VO~2~max               NA
  12   Neidig et al. 2003         HIV 60 (52:8)        Depression Aerobic capacity Stress        NA                                     NA                                   Graded exercise stress test                POMS          NA                NA         NA                       ↑ POMS
  13   Baigis et al. 2002         HIV 123 (89:20)      Aerobic capacity HRQOL                    NA                                     NA                                   Treadmill Stress test                      MOS-HIV       NA                NA         \- VO~2~max              \- MOS-HIV
  14   Smith et al. 2001          HIV 60 (52:8)        Body composition Aerobic capacity         Anthropometric measurements            NA                                   Graded exercise test Time on treadmill     NA            ↓ BMI ↓ TBF       NA         ↑ TT - VO~2~max          NA
  15   Perna et al. 1999          HIV 43 (18:10)       Aerobic capacity                          NA                                     NA                                   Graded exercise test                                     NA                NA         ↑ VO~2~peak ↑ O2 pulse   
  16   Terry et al. 1999          HIV 21 (14:7)        Body composition Aerobic capacity         Anthropometric measurements            NA                                   Time on treadmill                          NA            NI                NA         ↑ treadmill time         NA
  17   Stringger et al. 1998      HIV 34 (31:3)        Aerobic capacity HRQOL                    NA                                     NA                                   Graded exercise test                       QOL           NA                NA         ↑ VO~2~max               ↑ QOL
  18   LaPerrieri et al. 1990     HIV 50 (50:0)        Aerobic capacity                          NA                                     NA                                   Bicycle ergometer test                     NA            NA                NA         ↑ VO~2~max               NA
  19   Yarasheski et al. 2010     HIV 39 (34:5)        Body composition Muscle strength          DEXA                                   1RM testing                          NA                                         NA            ↑ LBM ↑ TMV       NA         NA                       NA
  20   Multimura et al. 2008^a^   HIV 97 (36:61)       Body composition Aerobic capacity HRQOL   Anthropometric measurements            NA                                   Shuttle test                               WHOQOL-BREF   ↓ % BFM           NA         ↑ VO~2~peak              ↑ QOL
  21   Hand et al. 2008           HIV 40 (30:10)       Aerobic capacity                          NA                                     NA                                   Graded treadmill stress test               NA            NA                NA         ↑ VO~2~peak              NA
  22   Pérez-Moreno et al. 2007   HIV 19 (19:0)        BC Strength AC HRQOL                      Body mass MRI                          6RM testing                          Stress test Cycle ergometer                QOL           NS                ↑ 6RM      ↑ VO~2~peak              NS
  23   Dolan et al. 2006          HIV 38 (0:38)        Body composition Aerobic capacity         Anthropometric measurements TC DEXA    1RM testing                          Treadmill stress test TCAM6                NA            ↑ CSMA            ↑ 1 RM     ↑ VO~2~peak ↑ TCAM6      NA
  24   Filipas et al. 2006        HIV 35 (35:0)        Aerobic capacity HRQOL                    NA                                     1RM testing                          Kasch pulse recovery test                  MOS-HIV       NA                NA         ↓ HR                     ↑ MOS-HIV
  25   Driscoll et al. 2004^a^    HIV 25 (20:5)        BC Strength Aerobic capacity              Anthropometric measurements DEXA TC    1RM testing                          Submaximal exercise stress test            NA            ↑ CSMA ↓ WHR      ↑ 1 RM     ↑ET                      NA
  26   Driscoll et al. 2004^b^    HIV 25 (20:5)        Body composition Muscle strength          Anthropometric measurements CT DEXA    1RM testing                          NA                                         NA            ↓ BMI ↓ TMA       NA         NA                       NA
  27   Rojas et al. 2003          HIV 33 (23:10)       Aerobic capacity HRQOL                    NA                                     NA                                   Graded exercise stress test                MOS-HIV       NA                NA         ↑ VO~2~max ↑ O2 pulse    ↑ MOS-HIV
  28   Grinspoon et al. 2000      HIV 43 (43:0)        BC Muscle strength                        CT DEXA                                2RM testing                          NA                                         NA            ↑ LBM ↑ CSMA      ↑ 1 RM     NA                       NA
  29   Rigsby et al. 1992         HIV 37 (37:0)        Muscle strength Aerobic capacity          NA                                     2RM testing                          YMCA cycle test protocol/Cycle ergometer   NA            NA                ↑ 1 RM     ↑ET ↓ HR                 NA

Male and female (M/F), dual energy X-ray absorptiometry (DEXA), magnetic resonance imaging (MRI), computed tomography (CT), bioelectrical impedance analysis (BIA), lean body mass (LBM), body weight (BW), body cell mass (BCM), thigh muscle volume (TMV), percentage body fat (% BFM), thigh muscle adiposity (TMA), body fat (BF), total body fat (TBF), waist-to-hip ratio (WHR) maximum voluntary contraction (MVC), mid-thigh cross-sectional muscle area (CSMA), 6 min walk test (TCAM6), exercise time (ET), time on treadmill (TT), health-related quality of life (HRQOL); Medical outcomes study HIV health survey (MOS-HIV); Profile of Mood States (POMS), not assessed (NA), significant improvement before and after the intervention and/or between groups (*p*\<0.05) (↑), significant reduction before and after the intervention and/or between groups (p\<0.05) (↓), no change (-), no improvement (NI).

###### 

Characteristics of the experimental intervention (resistance exercise) the trials included in the review.

  N    Study                    Intensity (RM)        Volume                               Muscle                  Contraction            Frequency (x wk)   Time (min)   Duration (wk)   Supervision (yes/no)
  ---- ------------------------ --------------------- ------------------------------------ ----------------------- ---------------------- ------------------ ------------ --------------- ----------------------
  1    Sakkas et al. 2009       80% RM                3 sets x 8 reps                      Upper body Lower body   NI                     3                  90           12              yes
  2    Lindegaard et al. 2008   50-60% RM 70-80% RM   3 sets x 12 reps4 sets x 8-10 reps   Upper body Lower body   Concentric/Eccentric   3                  45-60        16              NI
  3    Shevitz et al. 2005      80% RM                3 sets x 8 reps                      Large muscles           Dynamics               3                  30-60        12              yes
  4    Roubenoff et al. 2001    50-60% RM 75-90% RM   3 sets x 8 reps                      Large muscles           NI                     3                  NI           8               yes
  5    Agin et al. 2001         75% RM                3× (8-10) reps                       NI                      NI                     3                  NI           14              yes
  6    Bhasin et al. 2000       60% RM                3× (12-15) reps                      Upper body              NI                     3                  NI           16              NI
                                70-90% RM             4× (4-6) reps                        Lower body                                                                                     
  7    Strawford et al. 1999    80% RM                3 sets x 10 reps                     Major muscles           NI                     3                  60           7               yes
  8    Sattler et al. 1999      70% RM                3 sets x 8 reps                      Upper body              Concentric             3                  NI           12              yes
                                80% RM                                                     Lower body              Eccentric                                                              
  9    Lox et al. 1995          60% RM                3 sets x 10 reps                     NI                      NI                     3                  NI           12              yes
  10   Spence et al. 1990       15 RM                 1 set x 15 reps 3 sets x 10 reps     Bilateral               Concentric             3                  NI           6               yes

RM  =  repetition maximum; reps  =  repetitions; NI  =  no information.

###### 

Characteristics of the experimental intervention (aerobic exercise) in the trials included in the review.

       Study                    Modality                            Intensity/duration (wk)   Volume                                            Frequency (x per wk)   Time (min)   Length (wk)   Supervision
  ---- ------------------------ ----------------------------------- ------------------------- ------------------------------------------------- ---------------------- ------------ ------------- -------------
  1    Lindegaard et al. 2008   NI                                  65% HRmax/8 75% HRmax/8   5 min warm-up 35 min IT                           3                      40           16            yes
  2    Terry et al. 2006        Run                                 75-85% HRmax              15 min warm-up 30 min exercise 15 min cool-down   3                      60           12            yes
  3    Neidig et al. 2003       Treadmill Stationary bike Walking   50-70% HRmax              5 min warm-up 30 min exercise 5 min cool-down     3                      60           12            yes
  4    Baigis et al. 2002       Fitness Master ski machine          75-85% HRmax              10 min warm up 20 min exercise 10 min cool-down   3                      40           15            yes
  5    Smith et al. 2001        Walk or run Treadmill Jog           60-80 VO~2~max            5 min warm-up 30 min exercise 5 min cool-down     3                      30           12            yes
  6    Perna et al. 1999        IT Cycling exercise                 70-80% HRmax              3 min exercise task 2 min recovery                3                      45           12            yes
  7    Terry et al. 1999        Treadmill                           G1 - 60±4% HRmax          NI                                                3                      60           12            yes
                                                                    G2 - 80±4% HRmax                                                                                                              
  8    Stringer et al. 1998     Cycle ergometer                     G3 MI G4 HI               60 min IT 30-40 min IT                            3                      30-60        6             yes
  9    Lox et al. 1995          Bicycle ergometer                   50-80% HRres              5 min warm-up 24 min exercise 15 min cool-down    3                      45           12            yes
  10   LaPerrieri et al. 1990   Bicycle ergometer                   60-79% HRmax 80% HRmax    3 min exercise 2 min recovery                     3                      45           24            NI

HRmax  =  heart rate maximum; HRres  =  heart rate reserve; MI  =  moderate intensity; HI  =  heavy intensity; IT  =  interval training; NI  =  no information.

###### 

Characteristics of the experimental intervention (concurrent training) in the trials included in the review.

  N     Study                      Type exercise                         Intensity/duration (wk)                Volume                                             Frequency (x per Wk)   Time (min)   Length (wk)   Supervision
  ----- -------------------------- ------------------------------------- -------------------------------------- -------------------------------------------------- ---------------------- ------------ ------------- -------------
  1     Yarasheski et al. 2010     Aerobic exercise cycling/treadmill    50-85% Hres                            NI                                                 3                      90-120       16            Yes
                                   Resistance exercise                   12 RM                                  1-2 sets 12 reps                                   3                      90-120       16            Yes
  2     Mutimura et al. 2008       Aerobic exercise                      45% HRmax/3 60% HRmax/6 75% HRmax/15   15 min warm-up 60 min exercise 15 min cool-down    3                      90           24            Yes
                                   Resistance exercise                   NI                                     NI                                                 3                      90           24            Yes
  3     Hand et al. 2008           Aerobic exercise                      50-70% HRmax                           5 min warm-up 30 min exercise 5 min cool-down      2                      40           6             NI
                                   Resistance exercise                   12 RM                                  1 set, 12 reps                                     2                      20           6             NI
  4     Pérez-Moreno et al. 2007   Aerobic exercise Cycle ergometer      70-80% HRmax                           10 min warm-up 20 min exercise 10 min cool-down    3                      20-40        16            Yes
                                   Resistance exercise                   12-15 RM                               1-2 sets 12-15 reps                                3                      50           16            Yes
  5     Filipas et al. 2006        Aerobic exercise                      60% HRmax/3 75% HRmax/3                5 min warm-up 20 min exercise 5 min cool-down      2                      30           6             Yes
                                   Resistive exercise                    60% RM 80% RM                          3 sets 10 reps                                     2                      30           6             Yes
  *6*   Dolan et al. 2006          Aerobic exercise                      60% HRmax/2 75% HRmax/14               5 min warm-up 20-30 min exercise                   3                      35           16            Yes
                                   Resistive exercise                    60-70% RM/2 80% RM/12                  3-4 sets 8-10 reps                                 3                      85           16            Yes
  7     Driscoll et al. 2004       Aerobic exercise stationary bicycle   60% HRmax/2 75% HRmax/14               5 min warm-up 20-30 min exercise 5 min cool-down   3                      35           12            Yes
                                   Resistive exercise                    60-70% RM/4 80% RM/12                  3-4 sets 8-10 reps                                 3                      25           12            Yes
  8     Driscoll et al. 2004       Aerobic exercise stationary bicycle   60-75% HRmax                           5 min warm-up 20-30 min exercise 5 min cool-down   3                      36           12            Yes
                                   Resistive exercise                    NI                                     3 sets, 10 reps                                    3                      24           12            Yes
  9     Rojas et al. 2003          Aerobic exercise                      60-80% HRmax                           10 min warm-up 25 min exercise 10 min cool-down    3                      50           12            NI
                                   Resistive exercise                    60-70% RM/4 80% RM/12                  2-3 sets 8 reps                                    3                      NI           12            NI
  10    Grispoon et al. 2000       Aerobic exercise stationary bicycle   60-70% HRmax                           30 min exercise 15 min cool-down                   3                      30           12            Yes
                                   Resistive exercise dynamic            60-70% RM/6 80% RM/6                   2 sets, 8 reps 2 sets, 8 reps                      3                                   12            Yes
  11    Rigsby et al. 1992         Aerobic exercise                      60-80% HRmax                           2 min warm-up 30 min exercise 3 min cool-down      3                      36           12            NI
                                   Resistive exercise                    NI                                     1-3 sets 6-18 reps                                 3                      24           12            NI

HRmax = heart rate maximum; HRres = heart rate reserve; RM = repetition maximum; reps  =  repetitions; NI = no information.
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